LA JOLLA, Calif., Feb. 20, 2008 (PRIME NEWSWIRE) -- Duska Therapeutics, Inc. (OTCBB:DSKA), a biopharmaceutical company developing diagnostic and therapeutic products based on adenosine 5'-triphosphate (ATP) and P2 receptor-related technologies, announced today that James S. Kuo, M.D., M.B.A., Chairman and Chief Executive Officer, will present at the Winter Global Equities Conference on Monday, February 25, 2008 at 11:00 AM Pacific Standard Time. The conference will be held at The Palms Hotel in Las Vegas, Nevada.
